Although DNA hypermethylation within promoter CpG islands is highly correlated with tumorigenesis, it has not been established whether DNA hypermethylation within a specific tumor suppressor gene (TSG) is sufficient to fully transform a somatic stem cell. In this study, we addressed this question using a novel targeted DNA methylation technique to methylate the promoters of HIC1 and RassF1A, two well-established TSGs, along with a 
Introduction
DNA methylation, a tightly regulated process during normal development, frequently becomes dysregulated during disease development, including cancer (1-3). Although methylation-induced tumorigenesis has yet to be recapitulated experimentally, during somatic cell proliferation, environmental and extracellular signals can initiate changes in DNA methylation that contribute to clonal selection, altered cellular behavior, and ultimately tumorigenesis (4) (5) (6) . Hypomethylation and/or hypermethylation of specific loci, including tumor suppressor loci, were strongly associated with transformation and carcinogenesis (7, 8) , and genetic knockout of the DNA methyltransferases (DNMTs), resulted in global hypomethylation and tumorigenesis (9, 10) . Although a causative role for altered methylation at specific loci, particularly as an initiating neoplastic event, remains poorly understood, dormant stem cells, either pre-existing in tissues or arising from somatic cells, may play a role in cancer origin and prognosis (4) . Furthermore, because DNA hypermethylation of TSG has been documented in many cancers, and its spreading correlates with cancer progression (4), we hypothesized that abnormal DNA hypermethylation can disrupt somatic stem cell proliferation and differentiation, resulting in the development of neoplasia.
To directly examine the effect of aberrant DNA methylation on cellular physiology, we established a Targeted DNA Methylation method called "TDM" (11, 12) established an in vitro methylated DNA complementary to the target gene promoter region initiated recruitment of DNMT to the endogenous target loci. Consequently, DNMT-mediated methylation spreads within the promoter region of the target loci, ultimately silencing the target gene after cellular passages. In order to monitor progression of TDM and cellular transformation, we also developed a two-component system (11, 12) . The first component Furthermore, if target loci DNA methylation was sufficient to induce cellular transformation, an EGFP-expressing cell behaved like a tumor (11, 12) . It was of interest to use this system to initiate TDM in a somatic stem cell and monitor the subsequent effects on cellular transformation. Although spontaneous transformation of human MSC in vitro was recently described (13, 14) , genetic disruptions of the p53 pathway, but not retinoblastoma (Rb), was sufficient to transform a fat-derived MSC (15) , supporting the possibility that sarcoma could In the current study (work flow is illustrated in Supplementary Figure S1A) , we aimed to test the hypothesis that targeted DNA methylation is sufficient for cellular transformation, thus the promoter regions of HIC1 (hypermethylated in cancer 1) and RassF1A (ras associated family protein isoforms 1A), two TSGs reported to be frequently silenced by DNA methylation in cancer (16) (17) (18) , were cloned, methylated in vitro, and then transfected into the MSCs, individually or concurrently. HIC1 and RassF1A are involved in highly diverse, interacting cellular networks (16, 19, 20) , and their loss of function could result in the recently described phenomenon of oncogenic addiction through p53 pathway (5). We thus hypothesized that hypermethylation of HIC1 and RassF1A would not only to directly suppress their tumor suppressor function, but also disrupt multiple cellular networks, resulting in tumorigenesis and cancer progression.
Materials and Methods
MSC isolation and characterization. Human MSC isolation and culture were performed as described by K.D. Lee et al. (21) . MSC expansion medium, passages and culture condition were as described by Hsiao et al. (11) . Transfection. The methylated PCR products (0.4 μg) were denatured at 95°C and then transfected into 5×10 5 cells using DMRIE-C (Invitrogen), according to the manufacturer's instructions. Unmethylated PCR products were transfected as control. Cells were transfected three times at day 1, 3, and 5.
Semi-quantitative real-time methylation specific PCR (qMSP). The qMSP experiment was conducted and products were quantified according to the protocol described in Yan et al. (22) . Briefly, bisulfite converted genomic DNAs (0.5 μg) were subject to real-time PCR with methylation specific primers (Supplementary Table 2 ). The qMSP reactions were performed using the SYBR Green I PCR Kit (Toyobo) in an iQ5 Real-Time PCR instrument (Bio-Rad).
Melting analysis was performed followed by all of the PCR reactions to ensure a specific amplicon was generated. Col2A1 was used for standard curve construction and as loading Semi-quantitative RT-PCR, qRT-PCR. Total RNA isolation, first-strand cDNA synthesis, and detection of the transcripts were carried out as described (18) . Briefly, total RNA (2 μg) was reverse transcribed using the SuperScript III reverse transcriptase (Invitrogen). The ng/ml bFGF, 10 ng/ml PDGF). Morphological changes and NeuN expression were used to validate neuronal induction. Osteocyte induction medium consisted of DMEM, 10% FBS, 10 mg/ml penicillin/streptomycin, 100 nM dexamethasone, 10 mM β-glycerophosphate, and 50 μM L-ascorbic acid-2-phosphate. Cells were treated with the osteocyte induction medium for 10 days and then subject to alkaline phosphatase (Sigma-Aldrich) staining.
Construction of two-component reporter system.
The construction of HIC1 two-component reporter system is described and illustrated in Supplementary Figure reporter system construction is illustrated in Supplementary Figure S4) Figure 2C, right) . The me_RassF1A, RassF1A or control (unmethylated) HIC1 DNAs failed to induce the EGFP expression, further indicating that we successfully and specifically methylated the HIC1 promoter. Targeted HIC1 methylation had no effect on the methylation state of the endogenous RassF1A promoter and vise versa ( Figure 2D ), consistent with our previous report that the locus-specific TDM (11, 12) .
Combined transfection of me_HIC1 and me_RassF1A resulted in methylation of both endogenous loci, as determined by qMSP ( Figure 2D , left panels), as well as concomitant Table 3 ). Our finding that MSC transformation is strongly associated with altered p53 function is consistent with a previous report using genetic approaches (15) . Figure S9B) . Furthermore, me_SWH-treated MSC retained stemness markers, could be induced to differentiate ( Figure   6C ). However, these cells were not tumorigenic in nude mice assay ( Figure 6D 
Characteristics of me_H&R-transformed
Collectively, our data demonstrated that concurrent methylation of HIC1 and RassF1A was sufficient to transform MSCs. The observation that pluripotency was maintained suggests that the cells had acquired a CSC phenotype. Increased proliferation is often accompanied with increased genetic and/or epigenetic mutations (29) , which further enhance transformation and clonal selection during mesenchymal-to-epithelial transition (EMT) (30) (31) (32) . In more permissive environments, including nude mice, subpopulations of inoculated me_H&R produced NSE-and LCA-positive epithelial cells ( Figure 5C ) or other cell types (Supplementary Figure S10B) . The acquired differentiation capacity, and perhaps later migratory capability, may allow these CSC-like cells to either remain in their original location or migrate to form secondary tumors ( Figure 5D , bottom scheme). Bioinformatic analysis further revealed the presence of p53 binding elements within the targets identified by DMH (Supplementary Table 3 
Discussion
Here, we elucidated the role of DNA methylation in the transformation of somatic stem cells into CSC-like cells. Bone marrow-derived MSCs are known to play important roles in cancer progression and metastasis (33) (34) (35) . By providing a microenvironment that enhances primary tumor growth, invasiveness, and metastasis, MSCs have the capacity to mobilize to other organs, providing a niche suitable for the disseminated cancer cells to metastasize to distant tissues (33) . Our data demonstrate that in addition to these two permit more efficient cancer development. However, it is also possible that hypermethylation of RassF1A results in further epigenomic disturbances, rendering a cell more susceptible to cancer-causing insult(s). Our data further demonstrate that DNA methylation is a cause rather than a consequence of malignancy, and p53 may be at the center of this oncogenic transformation. p53-dependent apoptosis plays an integral part in tumor growth, progression, and drug resistance development (38) , and the tumor suppressor ability of both HIC1 and RassF1A is due to p53 activation. Thus, concordant silencing of HIC1 and RassF1A by DNA methylation may synergistically disrupt the p53-mediated apoptotic pathway and contribute to the observed tumorigenic ability of MSCs.
The origin of cancer stem cells or cancer initiating cells has been widely debated.
These cells may arise either from de-regulated somatic stem cells or from de-differentiated mature cells (4, 7, 8, (39) (40) (41) (42) . It has been reported that several hypermethylated genes, including HIC1 and RassF1A, in adult cancer are unmethylated in embryonic stem cells and only partially methylated in embryonic carcinomas (43). In this study, we demonstrate that 
